This study is currently not recruiting participants.
AI-powered
Prospective Randomized Study Comparing the Ahmed Glaucoma Valve and the Baerveldt Glaucoma Device
Investigation of an Investigational (Being Tested) Medication
Not Recruiting
18 years - 100 years
All
Phase
N/A
1 Location
Brief description of study.
No Description Available
Detailed description of study
No Description Available
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Glaucoma
-
Age: 18 years - 100 years
-
Gender: All
This study investigates an investigational medication for a specific condition. The purpose is to understand how this medication affects the condition and to gather information on its safety and effectiveness.
Participants in the study will undergo various procedures, which may include medical tests, assessments, and questionnaires to evaluate the effects of the investigational medication.
- Who can participate: Eligibility criteria are not provided. Please contact the study team for age criteria and key eligibility factors.
- Study details: Participants may receive either the investigational medication or a placebo. A placebo is an inactive substance that looks like the investigational medication but does not contain any medicine. Participants will be required to attend scheduled visits, complete questionnaires, and possibly undergo medical tests to monitor their response to the treatment.
Updated on
19 Feb 2024.
Study ID: 0512-30 (1011004027)
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
Please choose between Voice or SMS based delivery of verification code
or